Test Price
2,800 AED✅ Home Collection Available
ADAM9 Gene Cone‑Rod Dystrophy Type 9 Genetic Test in UAE
Executive Summary & Core Metrics
- Precision: 99.9% Diagnostic Sensitivity – ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139).
- Home Collection: VIP Mobile Phlebotomy with ISO‑Certified Cold‑Chain Transport, 8 AM–11 PM daily.
- Post‑Test Guidance: Telephonic Clinical Correlation & Genetic Counselling included.
- Insurance: Direct Billing Verification via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The ADAM9 gene NGS test identifies pathogenic variants associated with cone‑rod dystrophy type 9, an inherited retinal disorder leading to progressive vision loss. This DNA analysis empowers ophthalmologists and clinical geneticists with a molecular diagnosis for accurate prognosis, family screening, and personalised management.
| Feature | Our Test (NGS) | Standard Single‑Gene Sequencing |
|---|---|---|
| Variant Detection | Full gene sequencing, CNV + SNV analysis | Limited to known hotspots; may miss copy‑number changes |
| Methodology | Next‑Generation Sequencing (NGS) with bioinformatic validation | Sanger sequencing of selected exons |
| Turnaround Time | 3–4 weeks | 6–8 weeks (if batched) |
Physician Insight & Safety Protocols
“This genetic test sheds light on the molecular basis of cone‑rod dystrophy. However, a positive result must always be correlated with a comprehensive ophthalmic examination, electrophysiology, and detailed family history. We are here to help you interpret the findings within your clinical context.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics (DHA Registration ID: 9294403)
⚠️ Advisory Notice
Do not discontinue any prescribed treatment without consulting your physician. This test is for diagnostic guidance only and does not replace medical therapy.
Exclusion Criteria & Emergency Red Flags
- Testing for minors requires documented parental/guardian consent in compliance with Federal Decree-Law No. 4 of 2016 on Medical Liability and DHA regulations.
- Individuals with active systemic infection or recent blood transfusion (within 2 weeks) should postpone sample collection.
- Seek immediate ophthalmic care if you experience sudden vision loss, acute eye pain, or new‑onset floaters/flashes.
- A pre‑test genetic counselling session is mandatory; we arrange it at no extra cost.
Patient FAQ & Clinical Guidance
1. What is the ADAM9 gene test?
The ADAM9 gene test uses next‑generation sequencing to identify disease‑causing mutations in the ADAM9 gene with 99.9% sensitivity. It confirms cone‑rod dystrophy type 9, guides prognosis, and enables carrier testing for at‑risk relatives.
2. How is the test performed?
A DHA‑licensed phlebotomist collects a single blood sample at your home using an ISO‑certified cold‑chain kit; the sample is then analysed by NGS. The process is painless and takes less than 10 minutes, with results securely delivered online.
3. When will I receive my results?
Results are usually available in 3–4 weeks, and you will receive a telephonic clinical guidance session with our genetic counsellor to interpret the findings. A detailed written report is shared via a secure patient portal.
UAE Regulatory & Data Privacy Adherence
DNA Labs UAE operates under DHA Facility License No. 1143 and adheres to the highest standards of data protection and clinical governance. Our laboratory holds ISO 9001:2015 certification (Cert: INT/EGQ/2509DA/3139).
Patient data is processed in full compliance with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic results are encrypted and accessible only to the ordering physician and the patient through a secure portal.
Clinical safety and patient consent are governed by Federal Decree-Law No. 4 of 2016 on Medical Liability, ensuring every test is accompanied by informed consent and genetic counselling as required.
Clinical & Logistical Metadata
| Test Name | ADAM9 Gene Cone‑Rod Dystrophy Type 9 Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 weeks |
| Sample Type / Matrix | Whole Blood (Peripheral) |
| Methodology Used | Next‑Generation Sequencing (NGS) with Bioinformatic Validation |
| ICD-10-CM Code | H35.5 |
| LOINC Code | 83464-7 |
| DHA Facility License & Laboratory Address | DHA License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians